Cidqo

Barcelona, Spain Founded: 2012 • Age: 14 yrs Acquired By Suanfarma
Pharmaceuticals and intermediates are developed using combinatorial chemistry.

About Cidqo

Cidqo is a Healthcare company based in Barcelona (Spain) founded in 2012, and was acquired by Suanfarma in March 2013. Pharmaceuticals and intermediates are developed using combinatorial chemistry. Cidqo offers products and services including Organic Synthesis, Analytical Chemistry, Intellectual Property Evaluation, and Quality Assurance. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Services and Diversified. Its legal entity is CIDQO 2012, SL.

Company details

Cidqo was established in 2012 in Barcelona, Spain, within the pharmaceuticals sector. Combinatorial chemistry is employed for developing active pharmaceutical ingredients and intermediates. Services in API production are provided, with completed developments including N-Acetyl Cysteine (NAC), L-Carnosine, Dapoxetine, Tenofovir, Rivastigmine, and Diacerein. Ongoing efforts focus on Cinacalcet HCL, Adenine, and Emtricitabine.

  • Headquarters Barcelona, Spain
  • Stage Acquired
  • Sectors
    Healthcare
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website cidqo.com
  • Acquired by Suanfarma (Mar 2013)
  • Legal Name Cidqo 2012, Sl
Key Metrics

Products & Services of Cidqo

Cidqo offers a comprehensive portfolio of products and services, including Organic Synthesis, Analytical Chemistry, Intellectual Property Evaluation, and Quality Assurance.

Organic Synthesis
Chemical Services

Designs synthetic routes for APIs and intermediates.

Analytical Chemistry
Analytical Services

Develops and validates methods for HPLC and spectroscopy.

Intellectual Property Evaluation
Support Services

Evaluates patents and innovative chemical routes.

Quality Assurance
Regulatory Services

Provides regulatory support and process optimization.

Funding Insights of Cidqo

  • Total Rounds 2
  • Last Round Grant β€” $55,006
  • First Round $56,000

    (May 2015)

  • Investors Count 2

All 2 funding rounds of Cidqo with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Oct 2015$55,006Grant––
May 2015$56,000Grant––
Valuation history

3 investors in total: 3 institutional.

Investors in Cidqo

Cidqo has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Suanfarma, European Union and EIC Fund.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Government agency and accelerator focusing on innovative startups and SMEs
eicfund.euBrussels, Belgium
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
1958europa.euBrussels, Belgium
Generics, nutraceuticals, and APIs are developed by Suanfarma.
1993suanfarma.comMadrid, Spain
Premium access

Investor details for Cidqo

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Cidqo

4 dated milestones of Cidqo across 3 years, from founding to its latest funding, stage changes and deals.

  1. Founded Cidqo is founded.
  2. Exit Acquired by Suanfarma.
  3. Funding First funding round of $56K.
  4. Funding Latest funding round, Grant, of $55K.
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Cidqo

Cidqo was founded in 2012 and raised its 1st funding round 3 years after it was founded.

Cidqo is headquartered in Barcelona, Spain. It is registered at Barcelona, Catalonia, Spain.

Cidqo was established in 2012 in Barcelona, Spain, within the pharmaceuticals sector. Combinatorial chemistry is employed for developing active pharmaceutical ingredients and intermediates. Services in API production are provided, with completed developments including N-Acetyl Cysteine (NAC), L-Carnosine, Dapoxetine, Tenofovir, Rivastigmine, and Diacerein. Ongoing efforts focus on Cinacalcet HCL, Adenine, and Emtricitabine.

Cidqo offers Organic Synthesis, Analytical Chemistry, Intellectual Property Evaluation, and Quality Assurance.

Cidqo has 3 investors. Key investors include Suanfarma, European Union, and EIC Fund.

Cidqo operates through Cidqo 2012, Sl.

Yes. Cidqo was acquired by Suanfarma in March 2013.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available